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Role ofα-Galactosylceramide-
activated Vα14 Natural Killer T Cells in
the Regulation of Allergic Diseases
Chiaki Iwamura1 and Toshinori Nakayama1
ABSTRACT
Vα14 natural killer T (NKT) cells produce large amounts of both IL-4 and IFN-γ upon stimulation with a ligend,
α-galactosylceramide (α-GalCer), and play a crucial role in various immune responses, including allergic reac-
tions. Interestingly, Vα14 NKT cells are not essential for the induction of specific IgE response but they instead
tend to induce suppression of specific IgE upon α-GalCer activation in vivo. The suppression in the IgE produc-
tion is not detected either in Vα14 NKT cell-deficient mice or in IFN-γ-deficient mice. Therefore, activated Vα14
NKT cells are able to exert a potent suppressive activity on Th2 cell differentiation and subsequent IgE produc-
tion by producing a large amount of IFN-γ. In an OVA-induced asthma model, α-GalCer administration inhibited
airway inflammation and airway hyperreactivity by IFN-γ from activated Vα14 NKT cells, thus suggesting the
negative regulation of Th2-responses by the activated Vα14 NKT cells.
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INTRODUCTION
Vα14 natural killer T (NKT) cells belong to a novel
lymphoid lineage distinct from T cells, B cells or NK
cells, and they are characterized by the expression of
a single invariant antigen receptor encoded by Vα14
and Jα281 segments in association with a highly
skewed set of Vβs, mainly Vβ8.2.1-3 The invariant
Vα14Vβ8.2 receptor is not expressed on conven-
tional T cells and its expression is essential for the de-
velopment of Vα14 NKT cells. In fact, the deletion of
the Jα281 gene segment results in the selective loss
of NKT cell development (NKT-deficient mice),4
while the transgene of the invariant Vα14Vβ8.2 into
recombination-activating gene-deficient mice leads to
the development of only NKT cells without other lym-
phoid populations (NKT mice),5 thus suggesting the
existence of a unique antigen receptor only for NKT
cells, but not for conventional T cells. The most po-
tent ligand for the invariant Vα14 NKT antigen recep-
tor is a glycolipid, α-galactosylceramide (α-GalCer),
which is exclusively presented by CD1d, a class Ib
molecule monomorphic in nature.6,7 Vα14 NKT cells
are known to play critical roles in infectious diseases8
and in the regulation of immune responses, such as
in the maintenance of transplantation tolerance, the
inhibition of tumor development, and protection
against autoimmune disease development.1,9 We
herein review the role of Vα14 NKT cells in the regu-
lation of Th2 cell differentiation, Th2 responses and
the development of allergic asthma.
REGULATION OF TH1 AND TH2 CELL DIF-
FERENTIATION
Mouse CD4+ T cells can be divided into two distinct
subpopulations based on their cytokine production
pattern, and they are designed as IFN-γ producing
Th1, and IL-4 producing Th2 cells.10 The develop-
ment of Th1 and Th2 cells is central to the diversity
of CD4 T cell-dependent immune responses in infec-
tious, allergic and autoimmune diseases. Th1 cells
mediate delayed-type hypersensitivity and organ-
specific autoimmune diseases, whereas Th2 cells are
involved in the development of allergies and in the
defense against extracellular microorganisms.
Th1 and Th2 cells are thought to differentiate from
a common precursor and the direction of Th cell dif-
ferentiation into Th1 and Th2 cells is dependent on
Allergology Internatinal. 2007;56:1-6
REVIEW ARTICLE
1Department of Immunology, Graduate School of Medicine, Chiba
University, Chiba, Japan.
Correspondence: Dr. Toshinori Nakayama, Department of Immu-
nology (H3), Graduate School of Medicine, Chiba University, 1−8−
1 Inohana, Chuo-ku, Chiba 260−8670, Japan.
Email: tnakayama@faculty.chiba―u.jp
Received 10 October 2006.
2007 Japanese Society of Allergology
DOI: 10.2332allergolint.R-06-136
Iwamura C et al.
2 Allergology Internatinal Vol 56, No1, 2007 www.jsaweb.jp
Fig. 1 Two possible roles of Vα14 NKT cels in Th1/Th2 cel diferentiation.  Naïve CD4 
T cel diferentiate into Th1 or Th2 cels after antigen recognition by TCR in the presence of 
an appropriate cytokine, such as IL-4 for Th2 cels and IL-12 for Th1 cels. As for the role 
of activated NKT cels, two possible regulation of the Th1/Th2 cel diferentiation can be 
considered. (A) IL-4 produced by NKT cels induces Th2 diferentiation. (B) IFN- γ pro-
duced by NKT cels suppresses Th2 diferentiation.
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the exogenous cytokines. IL-12 is a potent inducer of
Th1 cells. Vα14 NKT cells are a primary target of IL-
12 and they produce only IFN-γ upon IL-12 stimula-
tion. This strongly suggests that Vα14 NKT cells
function as an inducer of Th1 cells, thus exerting a
suppressive activity on the generation of Th2 cells via
the production of IFN-γ under certain conditions. On
the other hand, IL-4 is required for the differentiation
of naïve T cells into Th2 effecter cells.11 In contrast to
Th1 and Th2 cells with a restricted ability to produce
particular cytokines, Vα14 NKT cells produce large
amounts of both IFN-γ and IL-4 after stimulation with
α-GalCer.5 As IL-4 and IFN-γ have an opposite effect
on Th2 cell differentiation, several mechanisms in the
regulation of Th2 cell differentiation by Vα14 NKT
cells have so far been reported (Fig. 1). Yoshimoto et
al. have demonstrated that IL-4 produced by NKT
cells to induce Th2 cell differentiation (see Fig. 1, A.
Induction by IL-4).12,13 In contrast, other reports by
several investigators have demonstrated that CD1d-
deficient or β2-microglobulin-deficient mice, with a
small number of NKT cells produce IgE upon immu-
nization with anti-IgD antibody at equivalent levels to
that in normal mice.14-17 A recent analysis suggested
that some NK1.1+TCRβ+ cells in certain lymphoid or-
gans, such as bone marrow or lymph node, were not
CD1d-dependent or Vα14Jα281-negative.18-20 Al-
though the NK1.1+TCRβ+ subpopulation may be a cell
source of IL-4, the activation requirements and func-
tion of the NK1.1+TCRβ+ subpopulation have not
been well analyzed. It is therefore important to evalu-
ate the functional role of Vα14 NKT cells in the regu-
lation of immune responses, particularly Th2 differen-
tiation and the subsequent IgE antibody responses.
SUPPRESSION OF IgG PRODUCTION BY
ACTIVATED Vα14 NKT CELLS
To investigate the role of Vα14 NKT cells in the regu-
lation of IgE antibody responses, Jα281-deficient
(Vα14NKT-deficient) mice were established where
the development of Vα14 NKT cells was dramatically
inhibited.4 Vα14 NKT-deficient mice were infected
with Nippstrongylus barasilensis (Nb), and then were
immunized with DNP-conjugated Nb in alum for the
induction of DNP-specific IgE production. Equivalent
levels of total IgE and DNP-specific IgE, compared to
the wild-type mice, were detected in Vα14 NKT-
deficient mice, where no primary IL-4 was produced.
In addition, the DNP-specific IgG1 and IgG2a levels
in Vα14 NKT-deficient mice were also comparable.
These results indicated that Vα14 NKT cells were not
indispensable for the antigen-specific IgE responses
induced by Nb infection immunization.21
It has been well documented that the IgE and IgG1
responses are mediated by antigen-specific Th2 cells,
and the IgG2a responses depend on Th1 cells. Conse-
quently, we activated Vα14 NKT cells in vivo with α-
GalCer, and the antigen-specific IgE, IgG1 or IgG2a
production was thus assessed. The anti-DNP IgE re-
sponse induced by DNP-OVA immunization dramati-
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cally decreased in wild-type mice after α-GalCer injec-
tion, whereas no suppression was observed in the
NKT-deficient mice. In the anti-DNP-IgG2a re-
sponses, however, a significant increase was ob-
served. These results indicated that the stimulation of
Vα14 NKT cells with α-GalCer suppressed the
antigen-specific Th2 responses, thus resulting in the
decreased IgE with either an intact or somewhat en-
hanced Th1-dependent IgG2a production. In contrast,
IL-4 produced by Vα14 NKT cells has little effect on
antigen-induced Th2 cell differentiation.21
INDUCTION OF TH2 PHENOTYPE BY Vα14
NKT CELL ACTIVATION
Repeated exposure to α-GalCer induced NKT cells to
secrete IL-4 but at dramatically reduced levels
IFN-γ.22,23 Similarly, the immunization of OVA and α-
GalCer in complete Freund’s adjuvant (CFA) effi-
ciently induced IgE response.24 We injected 2 μg
mouse α-GalCer after OVA priming in alum 3 times.21
This protocol was used because a potent anti-tumor
effect by Vα14 NKT cells was observed in an experi-
mental liver matastasis model of B16 melanoma.25 Al-
though the data are not shown, similar production
profiles of IFN-γ and IL-4 from Vα14 NKT cells were
observed in 2, 4 or 10 μg of α-GalCer injection (un-
published observation). Burdin et al.22 observed the
Th2-skewed cytokine profile after the repeated ad-
ministration of 4―5 μg of α-GalCer. Singh et al.24 used
4 μg of α-GalCer in CFA, by which α-GalCer may
stimulate Vα14 NKT cells repeatedly. It is thus con-
ceivable that the discrepancy between our results and
those of the other two groups is due to the differ-
ences in the protocol of α-GalCer administration.
ESSENTIAL ROLE OF IFN-γ IN THE REGU-
LATION OF IgE RESPONSES BY THE ACTI-
VATED Vα14 NKT CELLS
We extended our analysis using IFN-γ-deficient mice
and examined whether the effector molecule of the
Vα14 NKT cell mediated suppression of IgE response
is IFN-γ.21 IFN-γ-deficient mice were immunized with
OVA in alum after α-GalCer injection, and then the
primary IgE and IgG1 responses and secondary IgE
response were assessed. As we expected, no suppres-
sion in the reduction of IgE was observed in either
the primary or secondary response in IFN-γ-deficient
mice. In addition, the IgG1 response was not im-
paired. NKT cells in IFN-γ-deficient mice produced an
equivalent level of IL-4 upon stimulation with α-
GalCer. Therefore, the suppressive effect on the pro-
duction of IgE appears to be mediated by IFN-γ pro-
duced by Vα14 NKT cells (see Fig. 1, B. Suppression
by IFN-γ).
A suppressive effect on IgE production by IFN-γ
was reported in several other experimental sys-
tems.26-31 IFN-γ produced by γδ T cells suppressed
the IgE responses in OVA-specific responses30 and
the cutaneous contact sensitivity system.31 In addi-
tion, since IFN-γ is known to also be produced by
CD8+ αβ TCR T cells, a possible inhibitory role for
these cells in the regulation of IgE responses has also
been reported.32
When Vα14 NKT cells were found to produce
IFN-γ after activation with α-GalCer, a unique role of
IL-12 was reported.33,34 IL-12 is shown to be produced
by dendritic cells only when they interacted with
α-GalCer-activated Vα14 NKT cells. The IL-12 in turn
enhanced the IFN-γ production of the activated Vα14
NKT cells. As a result, IL-12 may play a significant
role in the IFN-γ-mediated suppressive effect on the
IgE responses.
INHIBITION OF TH2 CELL DIFFERENTIA-
TION BY ACTIVATED Vα14 NKT CELLS IN
VITRO
The role of ligand-activated Vα14 NKT cells on Th2
cell differentiation was examined more precisely
through the use of an in vitro induction culture sys-
tem.35 Naïve CD4 T cell obtained from (B6 × BALB
c) F1 mice were stimulated with immobilized anti-
TCR mAb in the presence of IL-4 to allow Th2 cell dif-
ferentiation in vitro. Vα14 NKT cells from α-GalCer-
treated Vα14 NKT mice with B6 background were
added to the induction culture, and the intracellular
production of IFN-γ and IL-4 in Kd-positive T cells was
assessed (Fig. 2). In this culture system, an IL-4 dose-
dependent increase in the generation of Th2 cells was
observed. However, the addition of activated Vα14
NKT cells in the induction culture inhibited IL-4-
producing Th2 cell differentiation. In addition, the
number of IFN-γ-producing Th1 cell differentiation
was significantly enhanced. These results clearly indi-
cated that Th2 cell differentiation was inhibited by
the addition of activated Vα14 NKT cells. Moreover,
the Vα14 NKT cell-mediated inhibition of Th2 cell dif-
ferentiation was blocked by the addition of anti-IFN-γ
mAb. Therefore, similar to the mechanisms govern-
ing IgE suppression in an in vivo experimental sys-
tem, IFN-γ thus appear to be an effector molecule for
the inhibition of Th2 cell differentiation induced by
activated Vα14 NKT cells in vitro (see Fig. 1, B. Sup-
pression by IFN-γ).
REGULATION OF AIRWAY INFLAMMATION
BY ACTIVATED Vα14 NKT CELLS
A suppressive effect of INF-γ from activated Vα14
NKT cells has been reported in several experimental
murine asthma model.36-38 Matsuda et al. showed that
a single administration of α-GalCer almost completely
abrogated the infiltration of eosinophils in the lung
and reduced airway hyperreactivity (AHR), together
with the decreased Th2 cytokine expression in BALF
and decreased goblet cell hyperplasia.36 This protec-
tion was accompanied by a significant increase in the
serum levels of antigen-specific IgG2a and a decrease
Iwamura C et al.
4 Allergology Internatinal Vol 56, No1, 2007 www.jsaweb.jp
Fig. 2 Inhibition of Th2 cel diferentiation by α-GalCer-activated Vα14 NKT cels. 
Naïve CD4 T cels (1.5×106) from (B6×BALB/c) F1 mice were stimulated with im-
mobilized anti-TCR mAb (H57-597; 30 mg/ml) in the presence of 1 or 10 U/ml of re-
combinant IL-4. Activated Vα14 NKT cels (0.75×106) from NKT mice with α-
GalCer treatment were added at the beginning of the induction culture.Where indi-
cated, anti-IFN- γ mAb (5 μg/ml) was added to the induction culture. Intracelular 
staining profiles of IL-4 and IFN- γ of electronicaly gated Kd-bearing T cels are 
shown. The percentages of cels present in each area indicated. 
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in those of antigen-specific IgE. This inhibitory effect
by α-GalCer administration was not observed in IFN-γ
KO mice. Furthermore, Hachem et al. demonstrated
the role of IFN-γ from NKT cells in the protection of
allergic asthma was shown by means of an adoptive
transfer system.37 The adoptive transfer of NKT cells
from OVA-sensitized and α-GalCer-treated mice sup-
pressed the OVA-induced AHR and airway inflamma-
tion in recipient mice. This protective effect was abol-
ished by the transfer of NKT cells from IFN-γ KO
mice, thus indicating that IFN-γ produced by NKT
cells is required for the transfer of the inhibiting ef-
fects of eosinophilia and AHR. These data suggest
that the specific activation of NKT cells by α-GalCer
inhibits the antigen-specific Th2 responses in the
lung and AHR, possibly by IFN-γ production.
In contrast, the requirement for NKT cells in the
development of the characteristic features of asthma
has been reported.39,40 Akbari et al. demonstrated
that Vα14 NKT cell-deficient mice were shown to de-
velop decreased AHR and OVA induced-airway in-
flammation, and the adoptive transfer of Vα14 NKT
cells producing IL-4 and IL-13 then completely re-
stored them.39 They concluded that Vα14 NKT cells
in the lung play a critical role in the development of
asthma, thus suggesting that the suppression of Vα14
NKT cell function might be a therapeutic strategy for
the treatment of asthma. They also proposed the in-
volvement of unknown self-antigens, which are ex-
posed during antigen challenge into the lung and
bind to CD1d, because OVA itself is unable to acti-
vate Vα14 NKT cells.
CONCLUSIONS
Since the number of Vα14 NKT cells is dramatically
reduced in the thymus and periphery in the Vα14
NKT-deficient mice, we conclude that Vα14 NKT
cells and their IL-4 production are not essential for
antigen-specific Th2 cell differentiation and the sub-
sequent IgE response induced by Nb infection and
OVA immunization. More interestingly, a unique
regulatory role of Vα14 NKT cells on Th2 cell differ-
entiation and a selective in vivo suppression of IgE
production in mice treated with α-GalCer during OVA
priming or Nb infection have been reported. OVA-
induced airway inflammation and AHR were sup-
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pressed by the activated Vα14 NKT cells,36-38
whereas the development of airway inflammation was
dependent on the presence of Vα14 NKT cells.39
These reports appear to be contradictory, and thus, a
more comprehensive analysis is required to establish
an optimal therapeutic strategy for allergic asthma us-
ing Vα14 NKT cells as a target. Recently, new endo-
genous and exgenous ligands that stimulate Vα14
NKT cells through distinct mechanisms independent
of α-GalCer have been reported.41,42 We need to await
the investigation on the involvement of these new
ligands in the Th2 immune responses and allergic
diseases. In any event, Vα14 NKT cells (Vα24 NKT
cells in human) may be an intriguing target for estab-
lishing a new strategy for the treatment of allergic
diseases.
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